Aggregate-selective removal of pathological tau by clustering-activated degraders
Science · 30.08.2024 · 385 (6712) · 1009-1016
DOI: 10.1126/science.adp5186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 30.08.2024. Verfasst von Jonathan Benn und 15 weiteren Autor:innen. Beteiligte Einrichtung: UK Dementia Research Institute at the University of Cambridge, Cambridge CB2 0AH, UK. Hauptthemen laut MEDLINE: Protein Aggregates, Protein Aggregation, Pathological, Proteolysis, Ribonucleoproteins. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, Medical Research Council.
Abstract (Originalsprache)
Selective degradation of pathological protein aggregates while sparing monomeric forms is of major therapeutic interest. The E3 ligase tripartite motif–containing protein 21 (TRIM21) degrades antibody-bound proteins in an assembly state–specific manner due to the requirement of TRIM21 RING domain clustering for activation, yet effective targeting of intracellular assemblies remains challenging. Here, we fused the RING domain of TRIM21 to a target-specific nanobody to create intracellularly expressed constructs capable of selectively degrading assembled proteins. We evaluated this approach against green fluorescent protein–tagged histone 2B (H2B-GFP) and tau, a protein that undergoes pathological aggregation in Alzheimer’s and other neurodegenerative diseases. RING-nanobody degraders prevented or reversed tau aggregation in culture and in vivo, with minimal impact on monomeric tau. This approach may have therapeutic potential for the many disorders driven by intracellular protein aggregation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UK Dementia Research Institute at the University of Cambridge, Cambridge CB2 0AH, UK.
- MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.
- CNRS EMR9002-BSI-Integrative Structural Biology, LabEx DISTALZ, F-59000 Lille, France.
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE, Risk Factors and Molecular Determinants of Aging-Related Diseases, F-59000 Lille, France.
- Université Lille, Inserm, CHU Lille, Lille Neuroscience & Cognition, LabEx DISTALZ, F-59000 Lille, France.
ORCID-Profile: Jonathan Benn, Shi Cheng, Sophie Keeling, Annabel E Smith, Dorothea Böken, Taxiarchis Katsinelos, Elian Dupré, Clément Danis, Isabelle Landrieu, Luc Buée, David Klenerman, Leo C James, William A McEwan
Förderung
- Wellcome Trust
- Medical Research Council
Zitieren
APA
Benn, J., Cheng, S., Keeling, S., Smith, A. E., Vaysburd, M. J., Böken, D., Miller, L. V. C., Katsinelos, T., Franco, C., Dupré, E., Danis, C., Landrieu, I., Buée, L., Klenerman, D., James, L. C., & McEwan, W. A. (2024). Aggregate-selective removal of pathological tau by clustering-activated degraders. Science, 385(6712), 1009-1016. https://doi.org/10.1126/science.adp5186
Vancouver
Benn J, Cheng S, Keeling S, Smith AE, Vaysburd MJ, Böken D, et al. Aggregate-selective removal of pathological tau by clustering-activated degraders. Science. 2024;385(6712):1009-1016. doi:10.1126/science.adp5186
BibTeX
@article{Benn2024,
author = {Benn, Jonathan and Cheng, Shi and Keeling, Sophie and Smith, Annabel E and Vaysburd, Marina J and Böken, Dorothea and Miller, Lauren V C and Katsinelos, Taxiarchis and Franco, Catarina and Dupré, Elian and Danis, Clément and Landrieu, Isabelle and Buée, Luc and Klenerman, David and James, Leo C and McEwan, William A},
title = {Aggregate-selective removal of pathological tau by clustering-activated degraders},
journal = {Science},
year = {2024},
volume = {385},
number = {6712},
pages = {1009--1016},
doi = {10.1126/science.adp5186}
}
EUVIMED